Original article
Thrombotic risk assessed by PAI-1 in patients with COVID-19: The influence of hyperglycemia and diabetes mellitus
Riesgo trombótico evaluado por PAI-1 en pacientes con COVID-19: la influencia de la hiperglucemia y la diabetes mellitus
Lourdes Basurtoa, Leticia Manuel-Apolinara,
, Ariadna Robledob, Sean O’Learyb, Carlos Martínez-Murilloc, Lina Ivette Medina-Ortíza, Mario German Montes Osoriod, Julio Zarazuaa, Lourdes Balcázar-Hernándeze, Juan Carlos Anda-Garayf
Corresponding author
a Endocrine Research Unit, Centro Medico Nacional Siglo XXI, IMSS, Av. Cuauhtémoc 330, Doctores, CP 06720 Mexico City, Mexico
b Department of Neurosurgery, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555, USA
c Hematology Department, Hospital General de México, Dr. Balmis 148, Doctores, Cuauhtemoc, 06720 Mexico City, Mexico
d Nuclear Medicine Department, Hospital de Especialidades, Centro Medico Nacional Siglo XXI, IMSS, Av. Cuauhtémoc 330, Doctores, CP 06720 Mexico City, Mexico
e Endocrinology Department, Hospital de Especialidades, Centro Medico Nacional Siglo XXI, IMSS, Av. Cuauhtémoc 330, Doctores, CP 06720 Mexico City, Mexico
f Internal Medicine Department, Hospital de Especialidades, Centro Medico Nacional Siglo XXI, IMSS, Av. Cuauhtémoc 330, Doctores, CP 06720 Mexico City, Mexico